BridgeMD
Tests treatment safety and results for Androgenetic Alopecia (AGA)
Official title Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
ClinicalTrials.gov ID: NCT07012486
What this study is testing
What is Oral DHA + Topical minoxidil 5%?
Oral DHA + Topical minoxidil 5% is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for androgenetic alopecia (aga).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is: Does DHA increase terminal hair follicles in the vertex area.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only
You may be able to join if
- Clinically diagnosed with androgenetic alopecia (AGA)
- No pregnancy plans within the next 6 months
You likely can't join if
- Patients who received systemic medications for hair loss within the past 2 months
- Use of topical medication for hair loss within the past 2 weeks
- Pregnancy or lactation
- Patients with known severe diseases of vital organs (e.g., heart, liver, kidney) or malignancies.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.